Revocation and Replacement of Authorisation of Persons to Import, Supply and Distribute Point-of-care Tests Under the COVID-19 Public Health Response (Point-of-care Tests) Order 2021
Pursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, the Director-General of Health, authorised the following persons or class of persons to import, supply, distribute, sell to other authorised persons or classes of persons, and use approved point of care rapid antigen tests:
The above persons or classes of persons are authorised to import, supply, distribute, sell, or use approved point of care rapid antigen tests for the Public Health Response or business health and safety.
The above persons or classes of persons are not authorised to import, supply, or use the point of care rapid antigen tests for their private or personal use.
The following point of care rapid antigen tests are approved for import and use in New Zealand:
Product name(s): SARS-CoV-2 Rapid Antigen Test (SD Biosensor) Manufacturer (country): SD Biosensor (Republic of Korea) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Product configuration: Professional or self-test of any package size |
Product name(s): PanBio COVID-19 Ag Rapid Manufacturer (country): Abbott Rapid Diagnostics Jena GmbH (Germany) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Product configuration: Professional or self-test of any package size |
Product name(s): CareStart COVID-19 Antigen Manufacturer (country): Access Bio Inc (United States of America) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Product configuration: Professional or self-test of any package size |
Product name(s): Atomo COVID-19 Antigen Test Manufacturer (country): Access Bio Inc (United States of America) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Configuration: Professional or self-test of any package size |
Product name(s): CLINITEST Rapid COVID-19 Antigen Test Manufacturer(s) (country): Healgen Scientific Limited Liability Company (United States of America) or Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Configuration: Professional or self-test of any package size |
Product name(s): Healgen Rapid COVID-19 Antigen Test and Manufacturer(s) (country): Healgen Scientific Limited Liability Company (United States of America) or Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Configuration: Professional or self-test of any package size |
Product name(s): BD Veritor System for Rapid Detection of SARS-CoV-2 and Manufacturer (country): Becton, Dickinson and Company (United States of America) Sample type(s): Nasal swab Configuration: Professional or self-test of any package size |
Product name(s): Sofia SARS Antigen FIA Test kit with Sofia and Sofia 2 analyser Manufacturer(s) (country): Quidel Corporation (United States of America) or Sample type(s): Nasal swab Configuration: Professional or self-test of any package size |
Product name(s): Ecotest COVID-19 Antigen Nasal Test Kit Manufacturer (country): Assure Tech (Hangzhou) Co Ltd (China) Sample type(s): Nasal swab or nasal pen Configuration: Professional or self-test of any package size |
Product name(s): STANDARD Q COVID-19 Ag Test and Manufacturer (country): SD Biosensor (Republic of Korea) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Configuration: Professional or self-test of any package size |
Product name(s): GenBody COVID-19 Ag Test Manufacturer (country): GenBody Inc. (Republic of Korea) Sample type(s): Nasal, nasopharyngeal, or oropharyngeal swab Configuration: Professional or self-test of any package size |
Dated this 3rd day of February 2022.
Dr ASHLEY BLOOMFIELD, Director-General of Health, Ministry of Health.
Note: This notice revokes and replaces “Amendment to the Notice of Expansion to Authorisation of Persons to Import, Supply and Distribute Point-of-care Tests Under the Public Health Response (Point-of-care Tests) 2021” published in the New Zealand Gazette, 28 January 2022, Notice No. 2022-go283; “Notice of Expansion to the Authorisation of Persons to Import, Supply and Distribute Point-of-care Tests Under the Public Health Response (Point-of-care Tests) 2021” published in the New Zealand Gazette, 25 January 2022, Notice No. 2022-go235; “Notice of Authorisation for Expanding Import, Supply and Distribution Under the COVID-19 Public Health Response (Point-of-care Tests) Order” published in the New Zealand Gazette, 21 January 2022, Notice No. 2022-go201.